Findings

What do systematic reviews say?

3,372 questions · 3,874 findings · 666 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 431 · 11.1%GRADE not reported 783 · 20.2%Very low 995 · 25.7%Low 909 · 23.5%Moderate 596 · 15.4%High 160 · 4.1%

Animal‐assisted therapy (AAT (live animal)) vs no AAT

Behaviour · people with dementia

1 finding from 1 review

Animal‐assisted therapy for dementia 2019 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 142 participants
Very low

Animal‐assisted therapy (AAT (live animal)) vs no AAT

Agitation and irritability · people with dementia

1 finding from 1 review

Animal‐assisted therapy for dementia 2019 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 143 participants
Very low

Animal‐assisted therapy (AAT (live animal)) vs no AAT

Health‐related quality of life measured using QUALID (12–45, higher score indicates poorer quality of life) · people with dementia

1 finding from 1 review

Animal‐assisted therapy for dementia 2019 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 164 participants
Moderate

Animal‐assisted therapy (AAT (live animal)) vs no AAT

ADL outcome · people with dementia

1 finding from 1 review

Animal‐assisted therapy for dementia 2019 · Cochrane Headline outcomes only
no estimate extracted
1 study · 37 participants
Low

Animal‐assisted therapy (AAT (live animal)) vs no AAT

Physical functioning: self‐care ability measured using MOSES Self‐Care Functioning subscale (8–32, higher score indicates poorer function) · people with dementia

1 finding from 1 review

Animal‐assisted therapy for dementia 2019 · Cochrane Headline outcomes only
no estimate extracted
1 study · 58 participants
Low

Intervention not reported

RVX (high dose, 10 mg to 20 mg) vs VKA · adults who underwent percutaneous coronary intervention and who have an indication for anticoagulation

1 finding from 1 review

Non‐vitamin K antagonist oral anticoagulants (NOACs) post‐percutaneous coronary intervention: a network meta‐analysis 2019 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 1546 participants
Very low

Intervention not reported

DAB (high dose, 150 mg) vs VKA · adults who underwent percutaneous coronary intervention and who have an indication for anticoagulation

1 finding from 1 review

Non‐vitamin K antagonist oral anticoagulants (NOACs) post‐percutaneous coronary intervention: a network meta‐analysis 2019 · Cochrane Headline outcomes only
no estimate extracted
1 study · 1527 participants
Low

Intervention not reported

RVX (high dose, 10 mg to 20 mg) vs VKA · adults who underwent percutaneous coronary intervention and who have an indication for anticoagulation

1 finding from 1 review

Non‐vitamin K antagonist oral anticoagulants (NOACs) post‐percutaneous coronary intervention: a network meta‐analysis 2019 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 1546 participants
Very low

Intervention not reported

DAB (high dose, 150 mg) vs VKA · adults who underwent percutaneous coronary intervention and who have an indication for anticoagulation

1 finding from 1 review

Non‐vitamin K antagonist oral anticoagulants (NOACs) post‐percutaneous coronary intervention: a network meta‐analysis 2019 · Cochrane Headline outcomes only
no estimate extracted
1 study · 1527 participants
Low

Intervention not reported

RVX (high dose, 10 mg to 20 mg) vs VKA · adults who underwent percutaneous coronary intervention and who have an indication for anticoagulation

1 finding from 1 review

Non‐vitamin K antagonist oral anticoagulants (NOACs) post‐percutaneous coronary intervention: a network meta‐analysis 2019 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 1542 participants
Very low

Intervention not reported

RVX (high dose, 10 mg to 20 mg) vs VKA · adults who underwent percutaneous coronary intervention and who have an indication for anticoagulation

1 finding from 1 review

Non‐vitamin K antagonist oral anticoagulants (NOACs) post‐percutaneous coronary intervention: a network meta‐analysis 2019 · Cochrane Headline outcomes only
no estimate extracted
1 study · 1393 participants
Low

Intervention not reported

DAB (high dose, 150 mg) vs VKA · adults who underwent percutaneous coronary intervention and who have an indication for anticoagulation

1 finding from 1 review

Non‐vitamin K antagonist oral anticoagulants (NOACs) post‐percutaneous coronary intervention: a network meta‐analysis 2019 · Cochrane Headline outcomes only
no estimate extracted
1 study · 1527 participants
Low

Intervention not reported

RVX (high dose, 10 mg to 20 mg) vs VKA · adults who underwent percutaneous coronary intervention and who have an indication for anticoagulation

1 finding from 1 review

Non‐vitamin K antagonist oral anticoagulants (NOACs) post‐percutaneous coronary intervention: a network meta‐analysis 2019 · Cochrane Headline outcomes only
no estimate extracted
1 study · 1389 participants
Low

Intervention not reported

DAB (high dose, 150 mg) vs VKA · adults who underwent percutaneous coronary intervention and who have an indication for anticoagulation

1 finding from 1 review

Non‐vitamin K antagonist oral anticoagulants (NOACs) post‐percutaneous coronary intervention: a network meta‐analysis 2019 · Cochrane Headline outcomes only
no estimate extracted
1 study · 1527 participants
Low

Intervention not reported

RVX (high dose, 10 mg to 20 mg) vs VKA · adults who underwent percutaneous coronary intervention and who have an indication for anticoagulation

1 finding from 1 review

Non‐vitamin K antagonist oral anticoagulants (NOACs) post‐percutaneous coronary intervention: a network meta‐analysis 2019 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 1542 participants
Very low

Intervention not reported

DAB (high dose, 150 mg) vs VKA · adults who underwent percutaneous coronary intervention and who have an indication for anticoagulation

1 finding from 1 review

Non‐vitamin K antagonist oral anticoagulants (NOACs) post‐percutaneous coronary intervention: a network meta‐analysis 2019 · Cochrane Headline outcomes only
no estimate extracted
1 study · 1527 participants
Low

MX exercise training vs control

HRQL FIQ Total. Scale from 0 to 100; high scores indicate worse quality of life Median length of interventions: 12 weeks · patients with fibromyalgia

1 finding from 1 review

Mixed exercise training for adults with fibromyalgia 2019 · Cochrane Headline outcomes only
no estimate extracted
13 studies · 610 participants
Moderate

MX exercise training vs control

Pain 10‐cm VAS scale (median · patients with fibromyalgia

1 finding from 1 review

Mixed exercise training for adults with fibromyalgia 2019 · Cochrane Headline outcomes only
no estimate extracted
15 studies · 832 participants
Moderate

MX exercise training vs control

Fatigue · patients with fibromyalgia

1 finding from 1 review

Mixed exercise training for adults with fibromyalgia 2019 · Cochrane Headline outcomes only
no estimate extracted
11 studies · 493 participants
Moderate

MX exercise training vs control

Stiffness · patients with fibromyalgia

1 finding from 1 review

Mixed exercise training for adults with fibromyalgia 2019 · Cochrane Headline outcomes only
no estimate extracted
5 studies · 261 participants
Low